Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis

Miriam J. Smith, Andrew J. Wallace, Naomi L. Bowers, Cecilie F. Rustad, C. Geoff Woods, Guy D. Leschziner, Rosalie E. Ferner, D. Gareth R Evans

    Research output: Contribution to journalArticlepeer-review


    Mutations of the SMARCB1 gene have been implicated in several human tumour predisposing syndromes. They have recently been identified as an underlying cause of the tumour suppressor syndrome schwannomatosis. There is a much higher rate of mutation detection in familial disease than in sporadic disease. We have carried out extensive genetic testing on a cohort of familial and sporadic patients who fulfilled clinical diagnostic criteria for schwannomatosis. In our current cohort, we identified novel mutations within the SMARCB1 gene and detected several mutations that have been previously identified in other schwannomatosis cohorts. Of the schwannomatosis screens reported to date, including our current dataset, SMARCB1 mutations have been found in 45 % of familial probands and 7 % of sporadic patients. The exon 1 mutation, c.41C >A, and the 3′ untranslated region mutation, c.*82C >T, are the most common changes reported in schwannomatosis disease so far, indicating mutation hotspots at both 5′ and 3′ portions of the gene. SMARCB1 mutations are found in a significant proportion of schwannomatosis patients, but there remains the possibility that further causative genes remain to be found. © Springer-Verlag 2012.
    Original languageEnglish
    Pages (from-to)141-145
    Number of pages4
    Issue number2
    Publication statusPublished - May 2012


    • Mutation
    • NF2
    • Schwannomatosis
    • SMARCB1


    Dive into the research topics of 'Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis'. Together they form a unique fingerprint.

    Cite this